[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
March 19, 1997

Selenium Supplementation and Cancer Rates

Author Affiliations

University of Pittsburgh Pittsburgh, Pa

JAMA. 1997;277(11):880. doi:10.1001/jama.1997.03540350030016

To the Editor.  —The article by Clark et al1 has very important implications. The results suggest that increased selenium intake results in a substantial reduction in cancer incidence in only 5 years. This is especially remarkable with regard to lung cancer, since the effects of smoking cessation usually require a much longer follow-up.2 These results can be due to (1) a true beneficial effect of selenium; (2) random variation, ie, type I error; and (3) an unexplained higher rate in the control group; in other words, the differences are not due to the benefit of selenium, but due to a much higher rate in the control group than would be expected. Unfortunately, the authors do not provide information on age- and sex-specific cancer rates in either group or the age distribution of cancer cases. They report a mean age of 63 years at entry, 75% men, and approximately 8000 person-years of observation.